Amgen Stock Outlook: Is Wall Street Bullish or Bearish?

By: barchartnews|2025/05/05 19:45:01
0
Share
copy
With a market cap of $151.2 billion, Amgen Inc. (AMGN) is a leading American biotechnology company headquartered in Thousand Oaks, California. Founded in 1980, Amgen specializes in discovering, developing, manufacturing, and delivering human therapeutics and has grown into one of the world's largest independent biotech firms.Shares of the drugmaker behemoth have underperformed the broader market over the past 52 weeks. AMGN has surged 1% over this time frame, while the broader S&P 500 Index ($SPX) has gained 12.3%. However, AMGN stock has risen 7.9% on a YTD basis, outperforming SPX's 3.3% YTD dip.Looking closer, the company has surpassed the Health Care Select Sector SPDR Fund's (XLV) 1.4% drop over the past 52 weeks and a marginal rise this year. www.barchart.com On May 1, Amgen delivered Q1 2025 earnings, and its shares dropped 2.5%. The company exceeded Wall Street expectations with an adjusted EPS of $4.90 and revenue of $8.1 billion. Key products like Prolia and Repatha saw strong sales growth, though Enbrel and Tepezza experienced declines. Amgen reaffirmed its full-year guidance and continues to focus on expanding its pipeline, including the promising obesity drug MariTide and its clinical-stage programs. The company is also investing $900 million to expand its U.S. manufacturing capabilities. For fiscal 2025, ending in December, analysts expect AMGN's EPS to grow 3.8% year-over-year to $20.59. The company's earnings surprise history is promising. It beat the consensus estimates in the last four quarters. Among the 30 analysts covering the stock, the consensus rating is a “Moderate Buy.” That’s based on 13 “Strong Buy” ratings, one “Moderate Buy,” 13 “Holds,” one “Moderate Sell,” and two “Strong Sells.” www.barchart.com The configuration is less bullish than a month ago, when the stock had 14 “Strong Buy” ratings.On May 2, RBC Capital Markets lowered its price target on Amgen from $324 to $320 but maintained an “Outperform” rating, following the company’s better-than-expected Q4 2024 earnings. AMGN’s mean price target of $317.69 represents a premium of 13% from the current market prices. The Street-high price target of $400 implies a modest potential upside of 42.2% from the current price levels. On the date of publication, Kritika Sarmah did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.

You may also like

Morning News | NYSE parent company invests in OKX; Morgan Stanley provides $500 million loan to Core Scientific; Western Union partners with Crossmint to launch stablecoin USDPT

March 5 Market Important Events Overview

These former crypto builders have transitioned to the hottest AI projects globally

From Crypto to AI: The once smartest and most restless group in the crypto world is quietly reshaping the power landscape of artificial intelligence.

Ethereum Overhaul 2026 Blueprint, this time to abandon "gradualism"

Standing at the historical turning point of "not advancing is retreating," the past gentle incremental iterations may no longer support Ethereum's vision of becoming the global settlement layer. This time, there is little time left for Ethereum's slow progress.

What Is OpenClaw? How AI Agents Could Change Crypto Exchange Trading

OpenClaw is a rapidly growing open-source AI agent that can autonomously execute tasks and interact with software, including connecting to crypto exchanges through APIs to analyze markets and automate trading strategies. While this creates new opportunities for smarter trading, it also introduces security and operational risks. Through this article, WEEX aims to help users better understand the potential and risks of AI trading agents so they can explore new technologies while trading more safely and responsibly.

Ethereum 2029 Strawmap Guide: Ultra-Fast Consensus, Native Privacy, and the "Acceleration Variables" Brought by AI

Understanding Ethereum 2029 "Sketch": 7 Upgrades, 5 Major Goals, and a "Theseus's Ship" Style Reconstruction.

Altcoin ETF Surge: SOL and XRP Inflows Total $23 Million as Institutions Diversify

Key Takeaways Institutional interest in altcoin ETFs is expanding, with SOL and XRP showing significant inflows on March…

Popular coins

Latest Crypto News

Read more